N-alkyl triphenylvinylpyridinium conjugated dihydroartemisinin perturbs mitochondrial functions resulting in enhanced cancer versus normal cell toxicity-Reference-Cited by-同舟云学术

N-alkyl triphenylvinylpyridinium conjugated dihydroartemisinin perturbs mitochondrial functions resulting in enhanced cancer versus normal cell toxicity

Published:2021-03 Issue: Volume:165 Page:421-434
ISSN:0891-5849
Container-title:Free Radical Biology and Medicine
language:en
Short-container-title:Free Radical Biology and Medicine

Author:

Varmazyad Mahboubeh,Modi Mira M.,Kalen Amanda L.,Sarsour Ehab H.,Wagner Brett^ORCID,Du Juan^ORCID,Schultz Michael K.,Buettner Garry R.,Pigge F. Christopher,Goswami Prabhat C.^ORCID

Funder

National Cancer Institute

Publisher

Elsevier BV

Subject

Physiology (medical),Biochemistry

Reference73 articles.

1. Cancer drug discovery by repurposing: teaching new tricks to old dogs;Gupta;Trends Pharmacol. Sci.,2013

2. Repurposing medicinal compounds for blood cancer treatment;McCabe;Ann. Hematol.,2015

3. Synthesis of novel coumarin nucleus-based DPA drug-like molecular entity: in vitro DNA/Cu(II) binding, DNA cleavage and pro-oxidant mechanism for anticancer action;Khan;PloS One,2017

4. Drug delivery and targeting;Langer;Nature,1998

5. Dual channel activatable cyanine dye for mitochondrial imaging and mitochondria-targeted cancer theranostics;Pan;ACS Biomater. Sci. Eng.,2017

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydroartemisinin‐driven TOM70 inhibition leads to mitochondrial destabilization to induce pyroptosis against lung cancer;Phytotherapy Research;2024-05-18

2. Repurposing Dihydroartemisinin to Combat Oral Squamous Cell Carcinoma, Associated with Mitochondrial Dysfunction and Oxidative Stress;Oxidative Medicine and Cellular Longevity;2023-02-16

3. Dihydroartemisinin synergistically enhances the cytotoxic effects of oxaliplatin in colon cancer by targeting the PHB2‐RCHY1 mediated signaling pathway;Molecular Carcinogenesis;2022-11-07